Since DMT1 silencing appears to result in a novel iron phenotype that is also found in metastasis-derived triple-negative breast cancer cell lines, we have evaluated the role of DMT1 in breast cancer metastasis. The gene discussed is SLC11A2; the disease is triple-negative breast carcinoma.